Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With Chronic HBV Infection [Phase 2]

View source ↗

Summary

A Phase 2 study assessing safety, tolerability, pharmacokinetics, and antiviral activity of IONIS-HBVRx in treatment-naïve chronic hepatitis B patients has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• IONIS-HBVRx (IONIS-HBVRx)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B, Chronic Hepatitis B Atypical | Phase 2 | Status: COMPLETED | Results posted: 2020-12-21